Navigation Links
Xhibit Corp. Signs Agency Of Record Agreement With ConvergenceHealth
Date:1/9/2013

Tempe, Arizona (PRWEB) January 09, 2013

Xhibit Corp. (OTCQB: XBTC) (“the Company” or “Xhibit”), a leader in digital marketing and advertising solutions and ConvergenceHealth, a leader in global health systems and technology, have entered an exclusive agreement for Xhibit Corp. to act as exclusive agency of record for ConvergenceHealth's digital media services effective January 8, 2013.

As the exclusive agency of record for ConvergenceHealth, Xhibit will provide the digital advertising, digital communications and digital media strategies that complement the sophisticated solutions that ConvergenceHealth currently provides its enterprise clients.

Previously, ConvergenceHealth worked with multiple providers to develop the external digital media and digital marketing components integral to the comprehensive strategic health improvement services ConvergenceHealth offers.
The transition to Xhibit as the selected single provider for digital marketing and advertising is intended to further enhance ConvergenceHealth’s efficiencies and secure access to the latest innovative approaches to digital media for its enterprise clients.

Chris Richarde, President and CEO of Xhibit states, "The health and wellness industry is a dynamic and rapidly progressive sector where clients can greatly benefit from innovation in digital ecosystems, digital media strategies, advertising and development. We look forward to working with ConvergenceHealth and the opportunity of providing cutting edge digital solutions to its client base. The strong value added client relationships ConvergenceHealth is known for, paired with Xhibit’s next generation digital solutions, creates a unique opportunity to bring more value to the global enterprise market ConvergenceHealth serves."

Byron Gehring, CEO of ConvergenceHealth adds, "I believe that keeping up with the latest innovative thinking in the digital communications arena is essential to the continued leadership and value we bring to our partnerships with global enterprise clients. With ConvergenceHealth's strong working relationships with notable companies such as Aetna and Humana that lead the Healthcare industry and globally recognized initiatives for population health improvement, I believe ConvergenceHealth is well positioned to capitalize on integrating Xhibit's superior digital development skills, and digital product solutions into its powerful health and wellness systems and strategies.”

About ConvergenceHealth
ConvergenceHealth is a leading global population health improvement systems and technology company designing and delivering customized, web-enabled health improvement platform applications for large-scale population health initiatives in the U.S., Central America and Europe with a focus on design and direction for effective engagement and communication strategies to drive participation and empowerment in population health programs. Global clients include the Federal Government of Mexico and leading U.S. health insurance companies and service providers, large employers and benefits providers serving more than 40 million users.

About Xhibit Corp.
Xhibit is a cloud based marketing and technology development company focused on digital advertising, mobile and social media development, and CRM (customer relationship management) solutions. Xhibit offers a total solution for digital advertising and marketing that is integrated throughout its divisions and shares technology and resources across all of its services. Through its subsidiaries, Xhibit utilizes its branded products and services to provide digital marketing and advertising solutions for top tier advertisers and agency clients.
For more information see http://www.xhibitcorp.com.
Contact:
Xhibit Corp.
Michael Schifsky, CFO
602-281-3554
mschifsky(at)xhibitcorp.com

###

Cautionary Statement Regarding Forward-Looking Information
This press release may contain certain "forward-looking statements" relating to the business of Xhibit Corp. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding the advantages of Xhibit's products and services, market acceptance of those products and services, the future success of any services developed for ConvergenceHealth, the business strategy, plans and objectives of Xhibit Corp.; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects", “intended” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results and ultimate corporate actions could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including, ConvergenceHealth’s ability to execute its business plans and maintain relationships with its customers, the demand for social media and viability of it for advertising, products and services developed by other companies that are competitive with this form of advertising, market share garnered by competitors, ability to maintain customer and vendor relationships, and those factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov), among other factors. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10305356.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Catalyst Exhibits Brings Big Presence to 2012 RSNA Show
2. Brian Su Announces the Invest in America 2013 (Shanghai) Summit and Exhibition
3. True-Dose to Exhibit Liquid Pet Supplements at the Cardinal Health Retail Business Conference in Orlando, FL on July 11-14
4. 2012 IDEA World Fitness Convention™: Zensah® to Exhibit Compression Apparel for Fitness Activities
5. Skillets & More Redesigns Its Facebook Page
6. MRIs reveal signs of brain injuries not seen in CT scans, UCSF/SFGH researchers report
7. More signs of the benefits of marriage?
8. Gastric Bypass Supplements Redesigns Their Leading Website
9. New DNA-Based Blood Test May Spot Signs of Cancer
10. Alzheimers Signs Found in Brains of Young Adults With Gene Mutation
11. Simple ovarian cancer symptom survey that checks for 6 warning signs may improve early detection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
(Date:2/23/2017)... RI (PRWEB) , ... February 23, 2017 , ... ... today a new partnership with the Rhode Island Consortium for Autism Research and ... an opportunity for children with autism spectrum disorder (ASD) to see films in ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... release fourth quarter and yearly financial results after ... management will host an investment-community conference call at ... on March 2 nd 2017 to discuss ...
(Date:2/23/2017)... , February 23, 2017 ... from increasing caseload for varicose veins in their body. ... globe are prompting the adoption of endovenous laser therapy ... global endovenous laser therapy market, published by ... of lifestyle choices and consequences of obesity have collectively ...
Breaking Medicine Technology: